{
  "ticker": "JNJ",
  "target_date": "2025-08-11",
  "actual_date": "2025-08-11",
  "collected_at": "2025-12-08T12:07:29.963385",
  "price": {
    "open": 171.05,
    "high": 172.23,
    "low": 170.71,
    "close": 171.46478271484375,
    "volume": 7256800,
    "change_1d_pct": 0.28,
    "change_7d_pct": 5.51,
    "change_30d_pct": 14.05
  },
  "technicals": {
    "rsi_14": 64.57,
    "sma_20": 165.26,
    "sma_50": 157.55,
    "macd": 3.862,
    "macd_signal": 3.598,
    "macd_histogram": 0.264,
    "bb_upper": 173.66,
    "bb_lower": 156.86,
    "price_vs_sma20_pct": 3.75,
    "price_vs_sma50_pct": 8.83,
    "volume_ratio": 0.78
  },
  "fundamentals": {
    "market_cap": 489050767360,
    "pe_ratio": 19.593147,
    "forward_pe": 19.149529,
    "price_to_book": 6.160956,
    "price_to_sales": 5.305908,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.35,
    "pct_from_52w_low": 44.25
  },
  "macro": {
    "spy": {
      "price": 634.16,
      "change_1d_pct": -0.2,
      "change_7d_pct": 2.28
    },
    "vix": {
      "level": 16.25,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.27
    },
    "dollar_index": {
      "level": 98.52
    },
    "gold": {
      "price": 3353.1
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?",
      "source": "Yahoo",
      "datetime": 1754926320,
      "summary": "MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected to drive a second-half rebound.",
      "url": "https://finnhub.io/api/news?id=d442286596621996ceafd5dc69f37ccb03f38b5bdff8a45c6c1d96394132cfec"
    },
    {
      "headline": "Wasatch Global Value Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1754920680,
      "summary": "The Wasatch Global Value Fund\u00e2\u0080\u0094Investor Class returned 5.69% in the quarter, slightly underperforming the MSCI AC World Value Index, which returned 5.84%.",
      "url": "https://finnhub.io/api/news?id=0d237a15b93b61b690ce7b4e090cc715672c9b063b8df0714337e96a2aec5daf"
    },
    {
      "headline": "Take the Zacks Approach to Beat the Markets: Digi Power X, RF Industries & Starbucks in Focus",
      "source": "Yahoo",
      "datetime": 1754912580,
      "summary": "Zacks spotlights Digi Power X, RF Industries and Starbucks as standout gainers amid market volatility and economic uncertainty.",
      "url": "https://finnhub.io/api/news?id=3d1236c9359ec5d2fd76679e31a6e2fb86d6d808c70f325b77bd33bfd62049e2"
    },
    {
      "headline": "Industry Analysis: Pharmaceuticals Like Novo Nordisk Offer Long-Term Opportunities",
      "source": "SeekingAlpha",
      "datetime": 1754907483,
      "summary": "Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks due to strong fundamentals and future AI benefits. Read more here",
      "url": "https://finnhub.io/api/news?id=256ea8bb2e23b7ca971a343047437044e07eec4a066f579cd2fa3dc2bb15f49b"
    },
    {
      "headline": "Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth",
      "source": "Yahoo",
      "datetime": 1754905080,
      "summary": "Multiple Myeloma is a cancer affecting plasma cells in bone marrow, often leading to weakened bones, anemia, and kidney damage. The production of abnormal M-proteins is a disease hallmark, detectable in blood or urine. While incurable, treatment advancements like chemotherapy, immunotherapy, and CAR",
      "url": "https://finnhub.io/api/news?id=9b792f2d80db8c118ae6948862869b5f26d134d3d1926bdd311f297bfab8402d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}